Covid Vaccines And Testing Boost CVS Health Earnings Outlook
CVS Well being raised its full-year earnings outlook as the pharmacy chain’s prospects race to get vaccinated in opposition to Covid-19 or examined for the virus because the Omicron variant surges throughout the U.S.
In a filing with the Securities & Exchange Commission forward of administration’s look on the digital J.P. Morgan Healthcare Convention, CVS stated it has raised its full 12 months 2021 diluted earnings per share steering “vary to $5.87 to $5.92 from $5.50 to $5.61 and raised its full 12 months 2021 adjusted earnings per share steering vary to $8.33 to $8.38 from a minimum of $8.00.
The Covid-19 pandemic has been a turbulent interval for drugstore chains like Walgreens and rival CVS Well being as they battled authorities shutdowns early on and prospects who didn’t need to depart their houses.
Currently, nevertheless, pharmacy chains are on a roll with prospects in search of assessments, vaccines and different well being gadgets in drugstores. CVS inventory has been close to or above a 52-week excessive and Walgreens final week reported internet revenue of $3.58 billion, or $4.13 in comparison with a lack of $308 million, or 36 cents a share within the year-ago quarter.
CVS, which reviews its fourth quarter and full-year